Literature DB >> 2095760

Limitations of tumour markers in screening.

J E Roulston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2095760     DOI: 10.1002/bjs.1800770903

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  7 in total

1.  The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors.

Authors:  Bing Wang; Qingyun Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-26       Impact factor: 4.553

2.  Simple method for comparing reliability of two serum tumour markers in breast carcinoma.

Authors:  D P O'Brien; D B Gough; R Skehill; H Grimes; H F Given
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

3.  Blood-based multiple-microRNA assay displays a better diagnostic performance than single-microRNA assay in the diagnosis of breast tumor.

Authors:  Hua Xin; Xiaoli Li; Bin Yang; Lening Zhang; Zhifeng Han; Chunshan Han
Journal:  Tumour Biol       Date:  2014-09-12

4.  Novel tumour markers: a diagnostic role in pancreatic cancer?

Authors:  J E Roulston
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

5.  The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer.

Authors:  Yanmei Jiang; Changfu Zhang; Kai Chen; Zhe Chen; Zhigang Sun; Zhuqing Zhang; Dongbing Ding; Shuangyi Ren; Yunfei Zuo
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

6.  Use of Biomarkers in Screening for Cancer.

Authors:  Michael J Duffy
Journal:  EJIFCC       Date:  2010-03-25

7.  Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.

Authors:  Lihua Liu; Shan Wang; Xiutang Cao; Jianchao Liu
Journal:  Tumour Biol       Date:  2014-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.